NKNzelle Delphine Kayem

Nzelle Delphine Kayem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nzelle Delphine Kayem has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the gaps and opportunities for development of an AMR educational package for higher education

    by Nzelle Delphine Kayem, Charlotte Cornbill, Muriel Dresen, Arya Gupta, Kristina Kadlec, Priyanka More, Afolake Atinuke Olanbiwoninu, Désirée Schaaf, Raju Sekar, Christina Stylianou, et al.

    Antimicrobial resistance (AMR) is a complex and rapidly evolving global health challenge that requires well-trained professionals within a One Health framework. However, AMR education remains fragmented, with limited interdisciplinary integration and inconsistencies across disciplines. Although AMR is included in undergraduate and postgraduate curricula in human medicine, veterinary medicine, biological sciences, and pharmacology, the educational focus differs substantially between fields. Moreover, teaching focuses on biomedical and pharmacological aspects, while social, behavioural, and policy dimensions are often underrepresented, limiting the ability to address AMR as a multifaceted societal challenge. To identify gaps in AMR teaching, associated challenges and unmet educational resource needs, we conducted a three-month international survey among professionals from diverse scientific fields involved in AMR teaching. A total of 85 professionals participated in the survey, of whom 94% were actively involved in AMR teaching. AMR was most often taught within microbiology (35%) or health-related (33%) courses and was typically presented as few lectures within a module (33%). Although the general perception was that engaging teaching approaches, such as case-based learning, better support effective learning, many participants (31%) reported relying primarily on traditional lecture-based materials. Furthermore, the survey identified limited curriculum time, behavioural barriers, and funding constraints as the principle challenges to effective education. Overall, these findings indicate a strong demand for additional teaching resources, particularly interactive and application-oriented materials that support active learning and interdisciplinary education. This knowledge will support the development of an open educational resource (OER)-based interactive online educational platform, designed to enhance AMR education within a One Health context and support the training of future health professionals.

  • Open Access

    Exploring the gaps and opportunities for development of an AMR educational package for higher education

    by Nzelle Delphine Kayem, Charlotte Cornbill, Muriel Dresen, Arya Gupta, Kristina Kadlec, Priyanka More, Afolake Atinuke Olanbiwoninu, Désirée Schaaf, Raju Sekar, Christina Stylianou, et al.

    Antimicrobial resistance (AMR) is a complex and rapidly evolving global health challenge that requires well-trained professionals within a One Health framework. However, AMR education remains fragmented, with limited interdisciplinary integration and inconsistencies across disciplines. Although AMR is included in undergraduate and postgraduate curricula in human medicine, veterinary medicine, biological sciences, and pharmacology, the educational focus differs substantially between fields. Moreover, teaching focuses on biomedical and pharmacological aspects, while social, behavioural, and policy dimensions are often underrepresented, limiting the ability to address AMR as a multifaceted societal challenge. To identify gaps in AMR teaching, associated challenges and unmet educational resource needs, we conducted a three-month international survey among professionals from diverse scientific fields involved in AMR teaching. A total of 85 professionals participated in the survey, of whom 94% were actively involved in AMR teaching. AMR was most often taught within microbiology (35%) or health-related (33%) courses and was typically presented as few lectures within a module (33%). Although the general perception was that engaging teaching approaches, such as case-based learning, better support effective learning, many participants (31%) reported relying primarily on traditional lecture-based materials. Furthermore, the survey identified limited curriculum time, behavioural barriers, and funding constraints as the principle challenges to effective education. Overall, these findings indicate a strong demand for additional teaching resources, particularly interactive and application-oriented materials that support active learning and interdisciplinary education. This knowledge will support the development of an open educational resource (OER)-based interactive online educational platform, designed to enhance AMR education within a One Health context and support the training of future health professionals.

  • Open Access

    Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study

    by Nzelle Delphine Kayem, Sylvanus Okogbenin, Joseph Okoeguale, Mojeed Momoh, Antonia Njoku, Reuben Eifediyi, Xavier Enodiana, Hilary Ngwu, Wilfred Irhiogbe, Yemisi Ighodalo, et al.

    Background: There is limited epidemiological evidence on Lassa fever in pregnant women with acute gaps on prevalence, infection incidence, and risk factors. Such evidence would facilitate the design of therapeutic and vaccine trials and the design of control programs. Our study sought to address some of these gaps by estimating the seroprevalence and seroconversion risk of Lassa fever in pregnant women.Methodology/Principal findings: We conducted a prospective hospital-based cohort between February and December 2019 in Edo State, Southern Nigeria, enrolling pregnant women at antenatal clinic and following them up at delivery. Samples were evaluated for IgG antibodies against Lassa virus. The study demonstrates a seroprevalence of Lassa IgG antibodies of 49.6% and a seroconversion risk of 20.8%. Seropositivity was strongly correlated with rodent exposure around homes with an attributable risk proportion of 35%. Seroreversion was also seen with a seroreversion risk of 13.4%.Conclusions/Significance: Our study suggests that 50% of pregnant women were at risk of Lassa infection and that 35.0% of infections might be preventable by avoiding rodent exposure and conditions which facilitate infestation and the risk of human-rodent contact. While the evidence on rodent exposure is subjective and further studies are needed to provide a better understanding of the avenues of human-rodent interaction; public health measures to decrease the risk of rodent infestation and the risk of spill over events may be beneficial. With an estimated seroconversion risk of 20.8%, our study suggests an appreciable risk of contracting Lassa fever during pregnancy and while most of these seroconversions may not be new infections, given the high risk of adverse outcomes in pregnancy, it supports the need for preventative and therapeutic options against Lassa fever in pregnancy. The occurrence of seroreversion in our study suggests that the prevalence obtained in this, and other cohorts may be an underestimate of the actual proportion of women of childbearing age who present at pregnancy with prior LASV exposure. Additionally, the occurrence of both seroconversion and seroreversion in this cohort suggests that these parameters would need to be considered for the development of Lassa vaccine efficacy, effectiveness, and utility models.


  • Open Access

    Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study

    by Nzelle Delphine Kayem, Sylvanus Okogbenin, Joseph Okoeguale, Joseph Eigbefoh, Joseph Ikheloa, Reuben Eifediyi, Xavier Enodiana, Olugbenga Emmanuel Olorogbogo, Isoken Aikpokpo, Yemisi Ighodalo, et al.

    Background: Evidence from previous studies suggest that Lassa fever, a viral haemorrhagic fever endemic to West Africa has high case fatalities, particularly in pregnancy. While there have been remarkable innovations in vaccine development, with some Lassa vaccines undergoing early clinical trials. An understanding of Lassa antibody kinetics and immune responses will support vaccine design and development. However, there is currently no evidence on the antibody kinetics of Lassa (LASV) in pregnancy. Our study sought to estimate the efficiency of transplacental transfer of LASV IgG antibodies from the mother to the child. Methodology/Principal findings: The study made use of data from a prospective hospital-based cohort of pregnant women enrolled at the antenatal clinic and followed up at delivery between February and December 2019. Blood samples from mother-child pairs were evaluated for antibodies against Lassa virus. The study demonstrates a transplacental transfer of LASV IgG of 75.3% [60.0–94.0%], with a significant positive correlation between maternal and cord concentrations and a good level of agreement. The study also suggests that transfer may be more variable in women with ‘de novo’ antibodies compared to those with pre-existing antibodies. Conclusions/Significance: The study shows that maternal antibody levels play an important role in determining transfer efficiency of Lassa antibodies to the new-born; and while the evidence is preliminary, the study also suggests that transfer efficiency may be less stable in acute or recent infection, as such timing of vaccination before pregnancy, that is in women of childbearing age may be more appropriate for protection of both pregnant women and their neonates.


  • Open Access

    Ebola virus disease in pregnancy: a systematic review and meta-analysis

    by Nzelle D Kayem, Charlotte Benson, Christina Y L Aye, Sarah Barker, Mariana Tome, Stephen Kennedy, Proochista Ariana, Peter Horby

    This review synthesises and appraises evidence on the effects of Ebola virus disease (EVD) in pregnancy. We searched bibliographic databases from dates of inception to November 2020, yielding 28 included studies. The absolute risk of maternal death associated with EVD was estimated at 67.8% (95% confidence interval [CI] 49.8 to 83.7, I2=85%, p2=31.0%, p=0.230). The absolute risk for foetal losses was estimated at 76.9% (95% CI 45.0 to 98.3, I2=96%, p2=0.0%, p=0.40). The gap analysis suggests limited or no data on the clinical course, non-fatal perinatal outcomes and EVD management in pregnant women. The review suggests that EVD has a high maternal and perinatal mortality, underscoring the urgent need for preventative and therapeutic solutions and improved screening and follow-up of pregnant women and newborns during outbreaks. There is not enough evidence to conclusively rule out pregnancy as a risk factor for mortality and there is limited evidence on the disease course, outcomes and management of EVD in pregnancy, and this supports the need for robust clinical trials and prospective studies that include pregnant women.


  • Open Access

    Lassa fever in pregnancy: a systematic review and meta-analysis

    by Nzelle D Kayem, Charlotte Benson, Christina Y L Aye, Sarah Barker, Mariana Tome, Stephen Kennedy, Proochista Ariana, Peter Horby

    Lassa fever is a zoonotic infection endemic to West Africa and is known to have adverse effects in pregnancy. We sought to synthesize and critically appraise currently available evidence on the effects of Lassa fever in pregnancy. An exhaustive bibliographic search from dates of inception to 30 September 2019 yielded 13 studies, from which individual patient data were extracted. The absolute risk of maternal death associated with Lassa fever was estimated at 33.73% (95% CI 22.05 to 46.42%, I2=72.40%, p=0.0014). The relative risk of death in pregnant women compared with non-pregnant women was estimated at 2·86 (95% CI 1.77 to 4.63, I2=27.27%, p=0.239). The formal gap analysis shows imprecise data on the risk of Lassa-related maternal and perinatal mortality and insufficient data for other pregnancy outcomes. The currently available evidence for the use of ribavirin in pregnant patients is not conclusive. With a threefold increased risk of mortality, there is a need to prioritize pregnant women as a special subgroup of interest for Lassa research. Robust prospective studies estimating the true incidence of adverse maternal and perinatal outcomes and randomized controlled trials to evaluate the efficacy of therapeutics for maternal Lassa virus infection are urgently needed.


  • Open Access

    Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries

    by Nzelle Delphine Kayem, Amanda Rojek, Emmanuelle Denis, Alex Salam, Andreas Reis, Piero Olliaro, Peter Horby

    We describe a pilot of the Clinical REsearch During Outbreaks (CREDO) initiative, a training curriculum for researchers in epidemic-prone low- and middle-income countries who may respond to disease outbreaks. Participants reported improved confidence in their ability to conduct such research and overall satisfaction with the course structure, content, and training.


  • Open Access

    A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic

    by A.M. Rojek, A. Salam, R.J. Ragotte, E. Liddiard, A. Elhussain, A. Carlqvist, M. Butler, N. Kayem, L. Castle, L.'O. Odondi, et al.